Edition:
United States

Minapharm Pharmaceuticals SAE (MIPH.CA)

MIPH.CA on Cairo Stock Exchange

70.58EGP
5 Dec 2016
Change (% chg)

-- (--)
Prev Close
£70.58
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,030
52-wk High
£76.02
52-wk Low
£25.70

MIPH.CA

Chart for MIPH.CA

About

Minapharm Pharmaceuticals SAE is an Egypt-based company engaged in the production and distribution of pharmaceutical products. The Company’s production falls into seven lines, namely Gastroenterology, Ophthalmology, Cardiology, Biogenetics, Dermatology, Dermatology, Orthopedic and Miscellaneous products such as betolvex,... (more)
No analyst recommendations are available for MIPH.CA.

Overall

Beta: 0.71
Market Cap(Mil.): £867.67
Shares Outstanding(Mil.): 12.29
Dividend: 4.50
Yield (%): 5.74

Financials

  MIPH.CA Industry Sector
P/E (TTM): 10.10 29.64 30.37
EPS (TTM): 6.99 -- --
ROI: 13.09 15.79 15.17
ROE: 12.65 16.91 16.51

BRIEF-Minapharm Pharmaceuticals Q3 consol profit rises

* Nine-month consol net profit EGP 101.6 million versus EGP 95.9 million year ago

Nov 29 2016

Earnings vs. Estimates

No consensus analysis data available.